• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冲击波疗法通过抑制细胞凋亡和铁死亡缓解低氧/复氧诱导的心肌细胞损伤。

Shock Wave Therapy Alleviates Hypoxia/Reoxygenation-Induced Cardiomyocyte Injury by Inhibiting Both Apoptosis and Ferroptosis.

机构信息

Department of Cardiology Beijing Hospital National Center of Gerontology Institute of Geriatric Medicine Chinese Academy of Medical Sciences, Beijing 100730, China.

Graduate School of Peking Union Medical College, Beijing, China.

出版信息

Anal Cell Pathol (Amst). 2024 Aug 14;2024:8753898. doi: 10.1155/2024/8753898. eCollection 2024.

DOI:10.1155/2024/8753898
PMID:39170930
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11338664/
Abstract

Shock wave therapy (SWT) is a new alternative therapy for patients with severe coronary artery disease that improves myocardial ischemic symptoms by delivering low-energy shock wave stimulation to ischaemic myocardium with low-energy pulsed waves. However, the specific mechanism of its protective effect is not fully understood, especially for the protective mechanism in cardiomyocytes after hypoxia/reoxygenation (H/R). We selected a rat H9c2 cardiomyocyte cell line to establish a stable H/R cardiomyocyte injury model by hypoxia/reoxygenation, and then used SWT for therapeutic intervention to explore its cardiomyocyte protective mechanisms. The results showed that SWT significantly increased cell viability and GSH levels while decreasing LDH levels, ROS levels, and MDA levels. SWT also improved mitochondrial morphology and function of cells after H/R. Meanwhile, we found that SWT could increase the expression of GPX4, xCT, and Bcl-2, while decreasing the expression of Bax and cleaved caspase-3, and inhibiting cardiomyocyte apoptosis and ferroptosis. Moreover, this protective effect of SWT on cardiomyocytes could be significantly reversed by knockdown of xCT, a key regulator protein of ferroptosis. In conclusion, our study shows that SWT can attenuate hypoxia-reoxygenation-induced myocardial injury and protect cardiomyocyte function by inhibiting H/R-induced apoptosis and ferroptosis, and this therapy may have important applications in the treatment of clinical myocardial ischemic diseases.

摘要

冲击波治疗(SWT)是一种治疗严重冠心病的新的替代疗法,通过向缺血心肌传递低能量脉冲波来改善心肌缺血症状。然而,其保护作用的具体机制尚不完全清楚,特别是对于缺氧/复氧(H/R)后心肌细胞的保护机制。我们选择大鼠 H9c2 心肌细胞系,通过缺氧/复氧建立稳定的 H/R 心肌细胞损伤模型,然后用 SWT 进行治疗干预,以探讨其心肌细胞保护机制。结果表明,SWT 可显著提高细胞活力和 GSH 水平,降低 LDH、ROS 和 MDA 水平。SWT 还改善了 H/R 后细胞的线粒体形态和功能。同时,我们发现 SWT 可以增加 GPX4、xCT 和 Bcl-2 的表达,降低 Bax 和 cleaved caspase-3 的表达,抑制心肌细胞凋亡和铁死亡。此外,SWT 对心肌细胞的这种保护作用可以通过敲低铁死亡的关键调节蛋白 xCT 而显著逆转。总之,我们的研究表明,SWT 可以通过抑制 H/R 诱导的细胞凋亡和铁死亡来减轻缺氧/复氧引起的心肌损伤,保护心肌细胞功能,这种治疗方法可能在治疗临床心肌缺血性疾病方面具有重要应用价值。

相似文献

1
Shock Wave Therapy Alleviates Hypoxia/Reoxygenation-Induced Cardiomyocyte Injury by Inhibiting Both Apoptosis and Ferroptosis.冲击波疗法通过抑制细胞凋亡和铁死亡缓解低氧/复氧诱导的心肌细胞损伤。
Anal Cell Pathol (Amst). 2024 Aug 14;2024:8753898. doi: 10.1155/2024/8753898. eCollection 2024.
2
The role and possible mechanism of the ferroptosis-related SLC7A11/GSH/GPX4 pathway in myocardial ischemia-reperfusion injury.铁死亡相关的SLC7A11/谷胱甘肽/谷胱甘肽过氧化物酶4通路在心肌缺血再灌注损伤中的作用及可能机制。
BMC Cardiovasc Disord. 2024 Oct 1;24(1):531. doi: 10.1186/s12872-024-04220-3.
3
Isoliquiritigenin alleviates myocardial ischemia-reperfusion injury by regulating the Nrf2/HO-1/SLC7a11/GPX4 axis in mice.异甘草素通过调节 Nrf2/HO-1/SLC7a11/GPX4 轴减轻小鼠心肌缺血再灌注损伤。
Free Radic Biol Med. 2024 Aug 20;221:1-12. doi: 10.1016/j.freeradbiomed.2024.05.012. Epub 2024 May 9.
4
Cardiac Shock Wave Therapy Alleviates Hypoxia/Reoxygenation-Induced Myocardial Necroptosis by Modulating Autophagy.心脏冲击波疗法通过调节自噬减轻缺氧/复氧诱导的心肌坏死性凋亡。
Biomed Res Int. 2021 Jan 19;2021:8880179. doi: 10.1155/2021/8880179. eCollection 2021.
5
Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis.柚皮素通过调节核因子红细胞 2 相关因子 2(Nrf2)/System xc-/谷胱甘肽过氧化物酶 4(GPX4)轴抑制铁死亡来减轻心肌缺血/再灌注损伤。
Bioengineered. 2021 Dec;12(2):10924-10934. doi: 10.1080/21655979.2021.1995994.
6
ADAM10 Alleviates Hypoxia/Reoxygenation-Induced Cardiomyocyte Injury by Activating the Notch Signaling Pathway.ADAM10 通过激活 Notch 信号通路减轻缺氧/复氧诱导的心肌细胞损伤。
Cell Biochem Biophys. 2024 Sep;82(3):2523-2532. doi: 10.1007/s12013-024-01365-y. Epub 2024 Jun 24.
7
Inhibition of miR-1224 suppresses hypoxia/reoxygenation-induced oxidative stress and apoptosis in cardiomyocytes through targeting GPX4.抑制 miR-1224 通过靶向 GPX4 抑制心肌细胞缺氧/复氧诱导的氧化应激和细胞凋亡。
Exp Mol Pathol. 2021 Aug;121:104645. doi: 10.1016/j.yexmp.2021.104645. Epub 2021 May 12.
8
Tanshinone IIA confers protection against myocardial ischemia/reperfusion injury by inhibiting ferroptosis and apoptosis via VDAC1.丹参酮 IIA 通过抑制 VDAC1 介导的铁死亡和细胞凋亡发挥抗心肌缺血再灌注损伤作用。
Int J Mol Med. 2023 Nov;52(5). doi: 10.3892/ijmm.2023.5312. Epub 2023 Oct 6.
9
Cardiac shock wave therapy protects cardiomyocytes from hypoxia‑induced injury by modulating miR‑210.心脏冲击波治疗通过调节 miR-210 保护心肌细胞免受缺氧诱导的损伤。
Mol Med Rep. 2020 Feb;21(2):631-640. doi: 10.3892/mmr.2019.10892. Epub 2019 Dec 18.
10
Hypoxia-elicited cardiac microvascular endothelial cell-derived exosomal miR-210-3p alleviate hypoxia/reoxygenation-induced myocardial cell injury through inhibiting transferrin receptor 1-mediated ferroptosis.缺氧诱导的心脏微血管内皮细胞衍生的外泌体 miR-210-3p 通过抑制转铁蛋白受体 1 介导的铁死亡缓解缺氧/复氧诱导的心肌细胞损伤。
Tissue Cell. 2022 Dec;79:101956. doi: 10.1016/j.tice.2022.101956. Epub 2022 Oct 13.

引用本文的文献

1
The interaction between ferroptosis and myocardial ischemia-reperfusion injury: molecular mechanisms and potential therapeutic targets.铁死亡与心肌缺血再灌注损伤之间的相互作用:分子机制与潜在治疗靶点。
Eur J Med Res. 2025 Jul 21;30(1):643. doi: 10.1186/s40001-025-02851-6.
2
Comprehensive Analysis Based on Genes Associated With Cuproptosis, Ferroptosis, and Pyroptosis for the Prediction of Diagnosis and Therapies in Coronary Artery Disease.基于与铜死亡、铁死亡和焦亡相关基因的综合分析对冠状动脉疾病的诊断和治疗进行预测
Cardiovasc Ther. 2025 Mar 15;2025:9106621. doi: 10.1155/cdr/9106621. eCollection 2025.
3
Assessment of the biosafety profile of on myoblasts and on chorioallantoic membrane.

本文引用的文献

1
DEAD-box helicase 17 (DDX17) protects cardiac function by promoting mitochondrial homeostasis in heart failure.DEAD-box 解旋酶 17(DDX17)通过促进心力衰竭中的线粒体动态平衡来保护心脏功能。
Signal Transduct Target Ther. 2024 May 24;9(1):127. doi: 10.1038/s41392-024-01831-2.
2
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets.缺血再灌注损伤:分子机制与治疗靶点。
Signal Transduct Target Ther. 2024 Jan 8;9(1):12. doi: 10.1038/s41392-023-01688-x.
3
Apigenin alleviates oxidative stress-induced myocardial injury by regulating SIRT1 signaling pathway.
对成肌细胞和成绒毛尿囊膜的生物安全概况评估。 (注:原文中“on myoblasts and on chorioallantoic membrane”中间少了内容)
World J Cardiol. 2025 Feb 26;17(2):102310. doi: 10.4330/wjc.v17.i2.102310.
芹菜素通过调节SIRT1信号通路减轻氧化应激诱导的心肌损伤。
Eur J Pharmacol. 2023 Apr 5;944:175584. doi: 10.1016/j.ejphar.2023.175584. Epub 2023 Feb 11.
4
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments.衰老和与衰老相关的疾病:从分子机制到干预和治疗。
Signal Transduct Target Ther. 2022 Dec 16;7(1):391. doi: 10.1038/s41392-022-01251-0.
5
Propofol Protects Myocardium From Ischemia/Reperfusion Injury by Inhibiting Ferroptosis Through the AKT/p53 Signaling Pathway.丙泊酚通过AKT/p53信号通路抑制铁死亡来保护心肌免受缺血/再灌注损伤。
Front Pharmacol. 2022 Mar 16;13:841410. doi: 10.3389/fphar.2022.841410. eCollection 2022.
6
Dexmedetomidine post-conditioning alleviates myocardial ischemia-reperfusion injury in rats by ferroptosis inhibition via SLC7A11/GPX4 axis activation.右美托咪定后处理通过 SLC7A11/GPX4 轴激活抑制铁死亡减轻大鼠心肌缺血再灌注损伤。
Hum Cell. 2022 May;35(3):836-848. doi: 10.1007/s13577-022-00682-9. Epub 2022 Feb 25.
7
Ferroptosis: A Potential Target in Cardiovascular Disease.铁死亡:心血管疾病的一个潜在靶点。
Front Cell Dev Biol. 2022 Jan 20;9:813668. doi: 10.3389/fcell.2021.813668. eCollection 2021.
8
Extracorporeal Cardiac Shock Wave-Induced Exosome Derived From Endothelial Colony-Forming Cells Carrying miR-140-3p Alleviate Cardiomyocyte Hypoxia/Reoxygenation Injury the PTEN/PI3K/AKT Pathway.携带miR-140-3p的内皮祖细胞来源的体外心脏冲击波诱导外泌体通过PTEN/PI3K/AKT途径减轻心肌细胞缺氧/复氧损伤
Front Cell Dev Biol. 2022 Jan 10;9:779936. doi: 10.3389/fcell.2021.779936. eCollection 2021.
9
The molecular mechanisms of ferroptosis and its role in cardiovascular disease.铁死亡的分子机制及其在心血管疾病中的作用。
Biomed Pharmacother. 2022 Jan;145:112423. doi: 10.1016/j.biopha.2021.112423. Epub 2021 Nov 17.
10
Ferroptosis: Opportunities and Challenges in Myocardial Ischemia-Reperfusion Injury.铁死亡:心肌缺血再灌注损伤中的机遇与挑战。
Oxid Med Cell Longev. 2021 Oct 23;2021:9929687. doi: 10.1155/2021/9929687. eCollection 2021.